Knowledge about the molecular structure of protein kinase A (PKA) isoforms is substantial. In contrast, the dynamics of PKA isoform activity in living primary cells has not been investigated in detail. Using a high content screening microscopy approach, we identified the RIIb subunit of PKA-II to be predominantly expressed in a subgroup of sensory neurons. The RIIb-positive subgroup included most neurons expressing nociceptive markers (TRPV1, NaV1.8, CGRP, IB4) and responded to pain-eliciting capsaicin with calcium influx. Isoform-specific PKA reporters showed in sensory-neuronderived F11 cells that the inflammatory mediator PGE 2 specifically activated PKA-II but not PKA-I. Accordingly, pain-sensitizing inflammatory mediators and activators of PKA increased the phosphorylation of RII subunits (pRII) in subgroups of primary sensory neurons. Detailed analyses revealed basal pRII to be regulated by the phosphatase PP2A. Increase of pRII was followed by phosphorylation of CREB in a PKA-dependent manner. Thus, we propose RII phosphorylation to represent an isoform-specific readout for endogenous PKA-II activity in vivo, suggest RIIb as a novel nociceptive subgroup marker, and extend the current model of PKA-II activation by introducing a PP2A-dependent basal state.
INTRODUCTION
Protein kinase A (PKA) represents a family of tetrameric kinases composed of regulatory (R) and catalytic (C) subunits. At low cAMP concentrations, PKA is maintained as an inactive R 2 C 2 holoenzyme. Binding of cAMP to R-subunits induces the dissociation of the holoenzyme complex and release of Csubunits facilitating substrate phosphorylation (Taylor et al., 1990) . Four regulatory (RIa, RIb, RIIa, RIIb) and four catalytic subunits (Ca, Cb, Cc, PrKX) give rise to multiple isoenzymes, categorized by their R-subunit class into PKA-I and PKA-II, respectively. These isoenzymes differ in their biochemical properties, expression pattern, interacting proteins, as well as their subcellular localization (Pidoux and Taskén, 2010) . Also, large variations in the quaternary structure of PKA-holoenzyme complexes have been described (Boettcher et al., 2011; Kim et al., 2007; Vigil et al., 2006; Wu et al., 2007; Zhang et al., 2012) . One difference between PKA-I and PKA-II is in their inhibitory domain, which blocks the catalytic subunit. Whereas RI subunits block the C-subunits by a non-phosphorylatable pseudosubstrate, RII subunits carry a serine within that inhibitory domain rendering them substrates of C-subunits. Recently, the analysis of cell homogenates and protein crystals suggested that RII subunits are fully phosphorylated already in the inactive PKA-II complex (Manni et al., 2008; Zhang et al., 2012) . However, whether this also applies to PKA-II in intact cells in vivo has not been conclusively investigated so far.
Knockout studies show that R-subunit isoforms are not functionally redundant (Amieux et al., 2002; Brandon et al., 1998; Cummings et al., 1996; Fischer et al., 2004; Huang et al., 1995; Rao et al., 2004; Thiele et al., 2000) . However, knockouts of R-subunits have limitations in revealing specific functions of PKA isoforms. Loss of one of the R-subunit isoforms might induce compensatory upregulation of other regulatory isoforms or result in increased free catalytic subunits, leading to uncontrolled excessive PKA activity (Amieux et al., 1997; Amieux et al., 2002) . Therefore, isoform-specific reporter constructs have been designed to analyze the differential involvement of PKA isoforms in cellular functions (Prinz et al., 2006a) . These approaches, however, require transfection of cells and therefore cannot be applied to many heterogeneous primary cell models. Thus, novel approaches are required to be able to evaluate the regulation and activity of endogenous PKA isoforms in wild-type cells.
Endogenous isoform-specific reporters of PKA activity are of crucial importance for the analysis of adult nociceptive neurons, which are highly heterogeneous and difficult to transfect. Nociceptive neurons react to intense thermal, mechanical or chemical stimuli and thereby initiate the feeling of pain (Basbaum et al., 2009) . They can be sensitized by various inflammatory mediators including agonists of Ga s -coupled GPCRs activating the PKA pathway (Hucho and Levine, 2007) . Indeed, PKA represents an indirect target of common pain medications such as opioids and non-steroidal anti-inflammatory drugs (NSAIDs) (Pierre et al., 2009) . PKA phosphorylates and sensitizes ion channels such as the voltage-gated sodium channel NaV1.8 and the transient receptor potential channel TRPV1, which are crucial for the functionality of nociceptive neurons (Bhave et al., 2002; England et al., 1996; Fitzgerald et al., 1999; Jeske et al., 2008; Rathee et al., 2002; Wang et al., 2007; Zhang et al., 2008) . Moreover, activation of the cAMP response-element-binding protein (CREB) may occur downstream of PKA to induce gene expression required for long-term sensitization (Ji et al., 2003) . Although most PKA studies in the context of pain have not taken into account the different isoforms, knockout of the RIb subunit indicated a small but significant involvement of PKA-I (Malmberg et al., 1997) . Whether PKA-II also is activated in nociceptive neurons in response to inflammatory mediators is unknown.
We set out to identify subgroup-specific expression of PKA regulatory subunits in nociceptive neurons. We then tested whether phosphorylation of RII subunits constitutes an endogenous read out for changes in PKA-II activity in vivo. By stimulating the neurons with various sensitizing inflammatory mediators we aimed to characterize neuronal subgroups responding to pain-sensitizing stimuli by the expression of nociceptive markers. Our data from fully quantitative and automated high content screening (HCS) microscopy suggest RIIb can be used as a marker for nociceptive neurons. Moreover, we propose a new dynamic model of baseline RII phosphorylation and its relation to the activity of PKA catalytic subunits.
RESULTS

All PKA regulatory subunits are expressed in DRG neurons
We analyzed the expression of the regulatory (RIa, RIb, RIIa, RIIb) and the catalytic (Ca and Cb) subunits of PKA by real-time PCR. Transcripts of all subunits were detected in mRNA samples of lumbar rat dorsal root ganglions (DRGs; Fig. 1A) .
To analyze the expression of the respective PKA subunit proteins, we tested antibodies for their specificity in HeLa cells transiently overexpressing GFP-tagged PKA subunits. All antibodies recognized their respective targets in immunoblots (Fig. 1B) . We observed slight cross reactivity of the RIb antibody to denatured RIa-GFP. Antibodies against the RII subunits, however, proved to be highly specific. In immunostainings of native GFP-tagged PKA regulatory subunits in intact HeLa cells, they showed no sign of cross-reactivity (Fig. 1C) corroborating tests of the RIIb antibody on tissues of Pkar2b knockout mice (Inan et al., 2006) . Using these evaluated antibodies, we detected all PKA regulatory subunits in lysates of rat DRGs by immunoblotting (Fig. 1D) .
To evaluate the expression of endogenous PKA subunits in DRG neurons at the single cell level, we established a quantitative HCS microscopy approach suitable for the analysis of large numbers of neurons. In brief, the microscope automatically acquires images of immunostained cultures in multi-well plates in up to four fluorescence channels. Neurons are identified by automated image analysis according to their expression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1, also known as PGP9.5) in combination with object selection parameters optimized for the sphere-like geometry of neurons after short-term culture ( Fig. 1E ; see Materials and Methods section). Lumbar DRGs (L1-L6) yielded 31,28863231 analyzable neurons per rat with a unimodal UCHL1 and cell size distribution (Fig. 1F,G) .
Using this HCS approach and the evaluated antibodies, we quantified the expression levels of PKA subunits in neurons and non-neuronal cells. In line with findings indicating that the expression pattern of b-isoforms is more restricted (Cadd and McKnight, 1989) , we detected b-isoforms only in neurons, whereas a-subunits were expressed also in non-neuronal cells. Ca/b, RIa, RIb and RIIa were found in all sensory neurons (Fig. 1H) . In contrast, RIIb was restricted to a subpopulation of neurons. Similar staining patterns were present in frozen DRG sections (Fig. 1I) .
RIIb is predominantly expressed in nociceptive neurons
RIIb was expressed in 6860.6% (n54, mean 6 s.e.m., total of 44110 neurons) of all cultured DRG neurons and 5860.9% of all neurons in sections (n54, mean 6 s.e.m., 12,706 neurons; Fig. 2A Fig. 2B ).
Sensory neurons are commonly grouped according the expression of nociceptive subgroup markers such as TRPV1, NaV1.8, calcitonin gene-related peptide (CGRP) and isolectin B4 (IB4), as well as of non-nociceptive markers such as neurofilament 200 (NF200) (Belmonte and Viana, 2008) . Using threshold-based quantification, we found 35% of neurons were TRPV1(+), 45% NaV1.8(+), 30% CGRP(+), 51% IB4(+) and 20% NF200(+) in overnight cultures (8000-10,000 neurons; Fig. 2D ) and 38% were TRPV1(+), 37% NaV1.8(+), 26% CGRP(+), 40% IB4(+) and 37% NF200(+) in sections (1365-4417 neurons, Fig. 2C ,E). In line with previous reports NF200 was mainly detected in large-diameter neurons whereas the nociceptive markers were expressed in smaller neurons (Fig. 2B) .
Testing for co-expression with RIIb, 94% of TRPV1(+), 95% of NaV1.8(+), 90% of CGRP(+) and 80% of IB4(+) neurons also expressed RIIb in cultured neurons (Fig. 2D) . Similarly, in sections 95% of TRPV1(+), 88% of NaV1.8(+), 92% of CGRP(+) and 82% of IB4(+) neurons co-expressed RIIb (Fig. 2E) . In contrast, only 40% and 30% of NF200(+) neurons co-expressed RIIb in cultures and sections, respectively. Large NF200(+) neurons are known to be Ab-fibers involved in proprioception but not in nociception. They did not express RIIb (Fig. 2D,E) . Smaller neurons co-expressing RIIb and NF200 (<10%) could be moderately myelinated Ad-fibers involved in the fast detection of first pain (Basbaum et al., 2009) . Therefore, RIIb expression predominates in smaller neurons, including most neurons defined by classical nociceptive markers.
Capsaicin-induced calcium influx occurs predominantly in RIIb(+) neurons
To corroborate that RIIb is enriched in nociceptors, we required functional confirmation. We therefore combined Fura-2-based calcium imaging and immunofluorescence analysis using our HCS platform. We stimulated DRG neurons with the paininducing TRPV1 ligand capsaicin (250 nM), monitored the calcium influx, and subsequently stained the same fixed cells for RIIb expression (Fig. 2F) . Capsaicin induced calcium influx in 3565% of all neurons (n53, total of 942 neurons). In line with immunofluorescence data, 9060.3% of the capsaicin-responsive neurons were RIIb(+). Moreover, the mean response amplitude was strongly increased in RIIb(+) neurons (Fig. 2G ).
Raising cAMP levels increases phosphorylation of RII in sensory neurons 
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Journal of Cell Science (2014 Science ( ) 127, 216-229 doi:10.1242 in the inactive PKA-II complex and dephosphorylated after dissociation of the holoenzyme. To test this model in primary sensory neurons, we first verified the specificity of monoclonal antibodies generated against the phosphorylated epitopes of RIIa (rabbit anti-pRII) or RIIb (mouse anti-pRII). Both antibodies were specific for the phosphorylated epitopes of in vitro phosphorylated recombinant RII subunits without discriminating between RIIa and RIIb (Fig. 3A) . Immunoblotting of DRG lysates resulted in double bands of the expected molecular masses (Fig. 3B ). In frozen DRG sections, both pRII antibodies produced highly similar staining patterns at the cellular level, although there was nuclear immunoreactivity with the mouse anti-pRII, which was not detected with the rabbit anti-pRII antibody (Fig. 3C ).
We then stimulated sensory neurons with the adenylyl cyclase activator forskolin expecting a decrease in pRII signals. To our surprise, forskolin did not decrease, but strongly increased, the pRII signals (Fig. 3D) . Signal intensities of both pRII antibodies correlated significantly (Spearman's r.0.9; Fig. 3E ). Because the dynamic range was higher for the rabbit pRII antibody, we used this antibody for all following experiments.
We performed dose-response and kinetic experiments pharmacologically raising the cellular cAMP concentration. Stimulation with forskolin for 4 minutes increased pRII levels 2.3-fold with a half-maximal effective concentration (EC 50 ) of 1.7 mM (Fig. 4A ). Also the membrane-permeable and phosphodiesterase-resistant cAMP analog Sp-8-Br-cAMPS-AM dose-dependently induced RII phosphorylation (EC 50 51.3 mM). Blocking phosphodiesterases with 3-isobutyl-1-methylxanthine (IBMX) to inhibit cAMP degradation also increased RII phosphorylation (Fig. 4A ). The kinetic response to these compounds was long-lasting, reaching plateau values after 5 minutes (Fig. 4B ).
The homeostatic level of phospho-RII depends on PP2A
The model of Zhang et al. suggests an immediate phosphorylation of RII subunits even if PKA-II is in a holoenzyme complex . Our data, however, show that activation of PKA-II results in a further increase of pRII levels. This suggests that the baseline homeostatic level of phosphorylated RII subunits is controlled by an interplay of catalytic subunits and phosphatases such as calcineurin (PP2B) (Oliveria et al., 2007; Rangel-Aldao and Rosen, 1976) or PP2A (Manni et al., 2008) .
We tested whether inhibition of phosphatases PP1, PP2A or calcineurin results in increased homeostatic baseline pRII levels. Treatment with the PP1/PP2A inhibitor calyculin A for 4 minutes resulted in a dose-dependent increase of pRII levels with an EC 50 of 1.7 mM (Fig. 4C) . Treatment with the PP1 inhibitor tautomycetin or the calcineurin inhibitor cyclosporine A did not result in accumulation of phosphorylated RII subunits (Fig. 4C ).
The homeostatic level of phospho-RII is increased in RIIb(+) neurons
Next we compared the basal phosphorylation levels of RIIbnegative [RIIb(2)] and RIIb(+) neurons at the single cell level. RIIb(+) neurons showed higher pRII levels than RIIb(2) neurons even in the unstimulated condition (2.560.1-fold; n53, 17,191 neurons; Fig. 4D ). This difference was maintained after stimulation with forskolin [2.160.1-fold in RIIb(2) versus 2.360.2-fold in RIIb(+); n53, 17,715 neurons] indicating that homeostatic pRII levels are regulated in a subgroup-specific manner.
Inflammatory mediators induce transient RII phosphorylation in subpopulations of sensory neurons
We applied a customized mixture modeling approach for the analysis of RIIb(2) and RIIb(+) neurons. The method provides the population-based estimate of responding versus nonresponding neurons in a threshold-free manner even if populations are largely overlapping (see the Materials and Methods section for details). Forskolin induced RII phosphorylation in 81.862.7% of RIIb (2) and 99.560.2% of RIIb(+) neurons (n53, 17,715 neurons) indicating that most neurons have the potential to react to increased levels of cAMP (Fig. 4E) .
Next we tested whether PKA-II is downstream of known sensitizing inflammatory mediators activating Ga s -coupled GPCRs. Stimulation with prostaglandin E 2 (PGE 2 ) for 30 seconds resulted in a dose-dependent RII phosphorylation with an EC 50 of 46 nM (Fig. 5A ). Prostacyclin (PGI 2 , EC 50 574 nM) induced a twice as strong response as PGE 2 (Fig. 5A) . Testing of several monoamines including serotonin (5-HT), histamine, dopamine, and the b-adrenergic agonist isoproterenol (Iso) revealed that only 5-HT and Iso, but not histamine and dopamine, significantly induced RII (2) and RIIb(+) neurons treated with forskolin (10 mM, red line) compared with the solvent control (0.1% DMSO, gray filled area). Thresholdfree mixture modeling (see Materials and Methods section) was applied to estimate the number of non-responsive (dashed black line) and responsive cells (dashed green line) from the modeled population (blue line). PDE, probability density estimation. Values are means 6 s.e.m. *P,0.05; **P,0.01; ***P,0.001. phosphorylation (Fig. 5B) . The EC 50 values were 14 nM for 5-HT and 33 nM for Iso, respectively. In contrast to the effects of cAMP analogs, PKA-II activation induced by inflammatory mediators was transient. Maximal responses were reached within 1 minute, returning to baseline within 5 to 60 minutes (Fig. 5C ).
In order to analyze the response to each inflammatory mediator at the single cell level, we stimulated DRG neurons for 1 and 4 minutes and immunostained for pRII and RIIb (Fig. 5D) . PGE 2 broadly activated RIIb(+) as well as RIIb(2) neurons, whereas responses to PGI 2 , 5-HT, and Iso were restricted to subpopulations. Notably, PGI 2 -and 5-HT-induced RII phosphorylation was significantly higher in RIIb(+) neurons (Fig. 5E) .
To show that raising cAMP levels also induces RII phosphorylation in non-neuronal cells such as glia, we quantified pRII levels in non-neuronal cells using a modified cell identification algorithm, which selects smaller sized, bright nuclei of cells lacking expression of UCHL1. We found that only forskolin and Iso, but not PGI 2 and 5-HT, significantly increased pRII levels in non-neuronal cells (Fig. 5G) .
We used our mixture modeling approach to quantify the percentage of responsive neurons and found strong differences between the inflammatory mediators with respect to the activated subpopulations. PGE 2 induced RII phosphorylation in 6965% of RIIb(2) and 9265% of RIIb(+) neurons after 1 minute stimulation (Fig. 5F, n53, 10,464 Thus, changes in pRII levels allow subgroup-specific analysis identifying that some inflammatory mediators activate PKA-II in most neurons (e.g. PGE 2 ) and others specifically act on subgroups (e.g. PGI 2 , 5-HT).
PGI 2 -and 5-HT-induced RII phosphorylation is followed by PKAdependent CREB phosphorylation
The expression of RIIb and the dynamic phosphorylation of RII allowed us to analyze the kinetics of ligand-induced signaling in a subgroup-specific manner. It remained unclear, however, if phosphorylation of RII subunits indicates increased activity of PKA-II catalytic subunits. We therefore tested whether the increase of pRII is followed by increased phosphorylation of a PKA downstream target such as the transcription factor CREB. CREB is phosphorylated at Ser133 within its kinase-inducible domain by several kinases including PKA and ERK1/2.
Stimulation with forskolin induced nuclear CREB phosphorylation in DRG neurons detected with a phosphoSer133-specific antibody (Fig. 6A) . Quantification of signal intensities from time course experiments revealed a long-lasting response upon forskolin stimulation (Fig. 6B) . Inflammatory mediators by contrast induced transient CREB phosphorylation, peaking 5 minutes after stimulation (Fig. 6B ). In agreement with CREB being a downstream target of PKA, the response kinetics were slightly slower than the pRII response (Fig. 5C) .
For an estimate of the number of responding cells, we analyzed pCREB/RIIb-labeled neurons stimulated for 4 minutes (Fig. 6C) . Basal pCREB levels were 1.360.01-fold higher in RIIb(+) compared with RIIb(2) neurons (n53, 11,268 neurons), probably reflecting the higher basal PKA-II activity in RIIb(+) neurons shown above. In line with the pRII-based subgroup analysis, we found that forskolin and PGE 2 induced CREB phosphorylation in both populations to a similar extent, whereas responses to PGI 2 and 5-HT were significantly higher in RIIb(+) neurons (Fig. 6D) .
Applying mixture modeling revealed that forskolin stimulation induced CREB phosphorylation in most neurons [7061% of RIIb(2) and 8862% of RIIb(+) neurons, n53, 10,407 neurons; Fig. 6E ]. PGE 2 induced a broad and rather weak response in both populations [5463% of RIIb(2) and 7467% of RIIb(+) neurons, n53, 11,392 neurons]. PGI 2 -induced CREB phosphorylation was restricted to RIIb(+) neurons (7963%, n53, 11,641 neurons). 5-HT acted on both populations, but the response was enhanced in RIIb(+) neurons [3866% of RIIb(2) and 6566% of RIIb(+) neurons, n53, 10,797 neurons].
To analyze whether CREB phosphorylation was dependent on PKA but not ERK1/2, we pretreated the neurons for 1 hour with the PKA inhibitor H89 or with the MEK inhibitor PD98059. CREB phosphorylation was blocked by the inhibitor of PKA but not of MEK (Fig. 6F) . To verify the effectiveness of PD98059, ERK1/2 phosphorylation induced by the nerve growth factor (1 nM, 30 minutes) was blocked by PD98059 (Fig. 7A) . Therefore, induction of RII phosphorylation indicates that there is activation of PKA-II as confirmed by PKA-dependent phosphorylation of its downstream target, CREB.
PGE 2 selectively activates PKA-II in DRG-derived F11 cells
Our pRII assay specifically detects the activation of PKA-II but not of PKA-I. In order to test all PKA isoforms for activation by inflammatory mediators, we employed bioluminescence resonance energy transfer (BRET) sensors. These are composed of Renilla luciferase-conjugated R-subunits (hRIa-RLuc, hRIIaRLuc and hRIIb-RLuc) as bioluminescent donor proteins and GFP-tagged catalytic subunits as acceptor proteins (Diskar et al., 2007; Prinz et al., 2006a; Prinz et al., 2006b ). In the inactive PKA complex the close proximity of luciferase and GFP results in energy transfer and a strong BRET signal. Activation of PKA by cAMP results in dissociation of the subunits reducing BRET signals.
Because BRET requires recombinant expression of fusion proteins, we switched to DRG-derived F11 cells. Forskolin strongly activated PKA-Ia, PKA-IIa and PKA-IIb sensors as indicated by the drop of the BRET signal to 71610%, 3067% and 2264%, respectively (Fig. 7B-D) . The inflammatory mediator PGE 2 also activated PKA. In contrast to forskolin, PGE 2 selectively activated PKA-IIa (6566%) and PKA-IIb sensors (7769%).
DISCUSSION
Dynamics of PKA-RII phosphorylation
Combinatorial assembly of catalytic and regulatory subunits results in diverse isoforms of the PKA family. Their quaternary structures differ substantially . A detailed analysis of isoform-specific cellular functions, however, remains challenging. Approaches to directly detect the activation of endogenous isoforms in primary cells models are largely missing. It was unclear whether changes in RII phosphorylation reflect the process of PKA-II activation. Early biochemical studies on PKA-II purified from bovine cardiac muscle showed that a large proportion of PKA-II is phosphorylated in vivo (Rangel-Aldao et al., 1979) . Another report suggests that RII subunits are fully phosphorylated in non-stimulated cardiomyocytes (Manni et al., 2008) . Accordingly, these researchers found that activation of PKA resulted in a phosphatase-dependent loss of basal RII phosphorylation detected in cell lysates (Manni et al., 2008) . The assumption that RII subunits are fully phosphorylated in the inactive holoenzyme complex was also suggested by the recently resolved crystal structure of the PKA-RIIb tetrameric holoenzyme (RIIb 2 :C 2 ) . Only the reaction products ADP and phosphorylated RIIb were detected after diffusion of MgATP into the RIIb 2 :C 2 crystals in the absence of cAMP . Based on these findings, Zhang et al. Using a novel HCS microscope approach for the analysis of adult sensory neurons, we found high variability of basal pRII levels. Especially high levels were detected in sensory neurons with high expression levels of RIIb (Fig. 4D) . Interestingly, these neurons coexpress markers of nociceptive neurons, suggesting that they are functionally distinct (Fig. 2C-E) . In contrast to the model of PKA-II activation depicted above, raising cAMP levels resulted in increased phosphorylation of endogenous RII subunits in our experiments. The induction of pRII was observed in response to activators of adenylyl cyclases, cAMP analogs, block of cAMP hydrolysis by phosphodiesterases, and ligand induced activation of Ga s -coupled GPCRs (Figs 4, 5) .
We believe, however, that our data are not contradictory to the recently published data. Rather, our findings extend the current model by further information about the basal state. Instant phosphorylation of RII, as suggested by Zhang et al. , could be counterbalanced in vivo by rapid dephosphorylation even in the absence of cAMP (Fig. 7E) .
Indeed, blocking the phosphatase PP2A in the absence of any stimulatory signal resulted in increased basal pRII signals (Fig. 4C) . This model is supported by the observed decrease of the K d for the interaction of RII with C-subunits following RII phosphorylation by factor of five (Rangel-Aldao and Rosen, 1976; Zimmermann et al., 1999) . Also studies using BRET sensors demonstrate that phosphorylation of RII subunits is required for the full dissociation of PKA-II holoenzymes in cell lines (Diskar et al., 2007) . Thus, we propose to extend the current model as follows: (I) RII subunits are instantly phosphorylated by C-subunits within the tetrameric RII 2 C 2 complex; (II) pRII has a higher probability for brief dissociation of the tetrameric complex; (III) free pRII subunits are rapidly dephosphorylated by PP2A and/or calcineurin, which induces reassociation of the complex followed by a new cycle of RII phosphorylation and dephosphorylation (Fig. 7E) .
The introduction of rapid turn-over at pRII in the basal state has important implications. Our data indicate that . RII subunits are phosphorylated by C-subunits within the tetrameric RII 2 C 2 complex resulting in dissociation of the complex. Rapid dephosphorylation by PP2A induces reassociation of the PKA-II complex followed by a new cycle of RII phosphorylation/dephosphorylation. Activation of adenylyl cyclases (AC) results in local production of cAMP, which binds to RII subunits. Binding of cAMP stabilizes RII phosphorylation and leads to the dissociation of the PKA-II complex resulting in release of active C-subunits phosphorylating nearby substrates. Degradation of cAMP by phosphodiesterases (PDEs) is followed by dephosphorylation and reassociation with free C-subunits.
measuring endogenous pRII levels allows the isoform-specific analysis of endogenous PKA-II activation even in hard to transfect cells such as the adult nociceptive neurons. The kinetics of RII phosphorylation measured here closely resemble the kinetics observed using the FRET-based sensor AKAR2 that monitors the activity of C-subunits (Zhang et al., 2005) . Furthermore, changes at the level of pRII resemble substrate phosphorylation because the response strength, kinetics and number of responding cells is similar for RII and CREB phosphorylation (Figs 5, 6 ). Also the dissociation constants from dose-response experiments are consistent with previous reports derived from reporter-based methods (Prinz et al., 2006a) . In line with our findings, increased RII phosphorylation was recently detected in spinal cord neurons following intrathecal injection of NMDA . As we found pRII responses in glia cells, this also applies to non-neuronal cell types (Fig. 5G) . We conclude that pRII antibodies can be used to analyze the isoenzyme-specific activation of endogenous PKA-II.
The investigation of the dynamics of RII phosphorylation revealed surprising aspects. Phosphorylation sites of RII are excellent substrates for the phosphatase calcineurin (PP2B), which has also been reported to colocalize with RII at the Cterminus of AKAP79/150 in neurons (Oliveria et al., 2007; Rangel-Aldao and Rosen, 1976) . We therefore assumed that dephosphorylation of RII is mediated by calcineurin. However, in nociceptive neurons it is not calcineurin but PP2A that seems to be involved in the regulation of the basal state (Fig. 4C ). This observation is in line with findings in cell lysates of forskolinstimulated cardiac myocytes in which dephosphorylation of RII subunits could also be inhibited by the PP2A inhibitor calyculin A (Manni et al., 2008) .
PKA-RIIb, a subgroup marker predominantly expressed in nociceptive neurons
We set out to investigate subgroup specificity of PKA isoforms. We found RIIb to be selectively expressed in a subgroup of sensory neurons (<60%, Fig. 2A) . Interestingly, the neurons in this subgroup include most neurons labeled by classical nociceptive markers and they are activated by the pain-eliciting TRPV1 agonist capsaicin (Fig. 2C-G) . Our findings therefore reveal that not only specific ion channels, but also signaling components modulating these channels, show subgroup-specific expression patterns and are enriched in nociceptive neurons. This suggests that also the intracellular signaling machinery defines the function of nociceptive subgroups. Currently there is no marker that exclusively identifies nociceptive neurons. As for the classical markers, RIIb is expressed predominantly in nociceptive neurons and thus may be used equally as a marker of nociceptive neurons. Nevertheless, further studies are required to clarify whether RIIb expression is restricted to nociceptive subgroups only or to what extend RIIb expression occurs also in some nonnociceptive subgroups (e.g. itch-specific neurons).
Inflammatory mediators modulate various ion channels including TRPV1, NaV1.8 and P2X3 in nociceptive neurons in a PKA-dependent manner (Bhave et al., 2002; England et al., 1996; Fitzgerald et al., 1999; Moriyama et al., 2005; Rathee et al., 2002; Wang et al., 2007) . Sensitization of TRPV1 depends on its association with AKAP79/150 to form a signaling complex that includes PKA (Bhave et al., 2002; Jeske et al., 2008; Rathee et al., 2002; Schnizler et al., 2008; Zhang et al., 2008) . This implies that PKA-II isoforms bound to AKAPs are more relevant for sensitization of ion channels in nociceptive neurons. Supporting this, our data demonstrate that the transcription factor CREB is downstream of PKA-II-mediated sensitization signaling and is predominantly activated in RIIb(+) neurons. This suggests a PKA-II-dependent induction of transcriptional long-term changes such as seen for example during chronification of pain.
We found that PGE 2 selectively activates PKA-II, but not PKA-I (Fig. 7B-D) . Also, a study using BRET sensors in COS-7 cells showed that stimulation of b-adrenergic receptors with isoproterenol selectively dissociated RIIa holoenzymes but not RIa holoenzymes (Prinz et al., 2006a) . In addition, we found inflammatory mediators to activate PKA-II in RIIb(+) as well as RIIb (2) neurons. This suggests that RIIa and RIIb are activated downstream of Ga s -coupled GPCRs in sensory neurons and are functionally redundant. Isoform replacement could therefore explain why knockout mice of individual RII isoforms present rather mild phenotypes (Brandon et al., 1998; Cummings et al., 1996; Rao et al., 2004) .
Our pRII assay allowed us to investigate the dynamics of PKA-II in subgroups of sensory neurons. To what extent inflammatory mediators act on sensory neurons has not been analyzed in detail so far. We found some inflammatory mediators to activate PKA-II in nearly all DRG neurons (e.g. PGE 2 ), whereas others acted on subgroups of RIIb (2) and RIIb(+) neurons (e.g. 5-HT, Iso) or even specifically activated RIIb(+) neurons only (e.g. PGI 2 ; Fig. 5F ). The observation that PGI 2 induces RII and CREB phosphorylation selectively in RIIb(+) neurons underlines the importance of RIIb as a possible marker predominantly expressed in nociceptive subgroups. Peripheral sensitization by PGI 2 acting on IP 1 receptors is well described (Pulichino et al., 2006) . Mice deficient for the PGI 2 receptor showed reduced inflammation and pain comparable with that of NSAID treatment in models of acute and chronic inflammation (Murata et al., 1997; Pulichino et al., 2006) . In contrast to PGE 2 , PGI 2 -induced sensitization is restricted to the peripheral sensory system and does not occur within the spinal cord (Pulichino et al., 2006; Reinold et al., 2005) . This corroborates that RIIb(+) neurons are enriched for nociceptive neurons and identifies PKA-RIIb downstream of IP1 receptors as a potential novel therapeutic target in the peripheral nervous system.
The great challenge of signaling analysis is the identification of isoform-specific actions in subgroups of primary cells. The novel HCS microscopy approach presented here enables the investigation of PKA-II dynamics in intact primary sensory neurons. Analyzing more than 1 million neurons, this approach elucidated the dynamic nature of the PKA-II basal state as well as subgroup-specific actions of inflammatory mediators. Beyond the suggestion of a new potential therapeutic target and the extension of the current model of PKA-II activation, our work further proposes a general assay for the analysis of endogenous PKA-II activation in primary cells. (Cell Signaling, no. 5675; WB 1:5000, IC 1:1000) , rabbit polyclonal antiRIb (Abm, no. Y051648; WB 1:2500, IC 1:500), mouse monoclonal antiRIIa (BD Transduction Laboratories, no. 612242; WB 1:5000, IC 1:500), mouse monoclonal anti-RIIb (BD, no. 610625; WB 1:5000, IC 1:2000) , mouse monoclonal anti-phospho-RIIb (S114) (BD, no. 612550; WB 1:2000 , IC 1:1000 , rabbit monoclonal anti-phospho-RIIa (S96) (Abcam, no. ab32390; WB 1:2000 , IC 1:1000 , chicken polyclonal anti-UCHL1 (Novus, no. NB110-58872; IC 1:2000) , rabbit polyclonal anti-TRPV1 (Alomone, no. ACC-030; IC 1:1000), mouse monoclonal antineurofilament 200 labeled with Alexa Fluor 488 (Sigma-Aldrich, no. N0142; IC 1:500), rabbit polyclonal anti-CGRP (Bachem, no. T-4032; IC 1:1000), rabbit polyclonal anti-NaV1.8 (Abcam, no. ab63331; IC 1:500), FITC-conjugated isolectin B4 (Sigma, L2895; IC 1:2500), highly crossadsorbed Alexa-Fluor-647-, -594 and -488-conjugated secondary antibodies (Invitrogen).
Reagents Forskolin (no. F3917), 3-isobutyl-1-methylxanthine (IBMX, no. I7018), GR113808 (#G5918), serotonin hydrochloride (5-HT, no. H9523), histamine dihydrochloride (no. H7250), dopamine hydrochloride (no. H8502), (2)-isoproterenol hydrochloride (no. I6504), cyclosporine A, and capsaicin were from Sigma-Aldrich. Phosphate tris(acetoxymethyl)ester (PO 4 -AM 3 , no. P030-003), 8-bromoadenosine 39,59-cyclic monophosphorothioate, Spisomer and acetoxymethyl ester (Sp-8-Br-cAMPS-AM, no. B029) were from Biolog LSI. PGE 2 (no. 14010) and PGI 2 (no. 18220) were from Cayman. PD98059 was from Calbiochem. H89 dihydrochloride, calyculin A and tautomycetin were from Tocris. All drugs were prepared as 10-100 mM stocks in distilled water, PBS, DMSO or ethanol.
Real-time PCR
RNA was isolated using Trizol (Invitrogen). One mg total RNA was reverse transcribed using the Multi-Scribe RT kit (Applied Biosystems). Reactions were performed in triplicate using TaqMan probes. FAMcoupled TaqMan probes (Rn00566036, Rn01756450, Rn00709403, Rn01293014, Rn01432302, Rn01748544, Rn00667869) were from Applied Biosystems.
Immunoblotting L1-L6 DRGs were pulverized in liquid nitrogen and lysed in 1 ml lysis buffer (15 mM Tris-HCl (pH 7.5), 8 M urea, 8.7% glycerol, 1% sodium dodecyl sulfate, 143 mM b-mercaptoethanol). Lysates were homogenized (QIAShredder, Qiagen), denatured for 5 minutes at 95˚C, loaded (10 mg), separated by SDS-PAGE, and transferred to PVDF membranes (Millipore). After blocking in Tris-buffered saline (TBST) with 2.5% milk powder at 4˚C overnight, membranes were incubated with the primary antibody diluted in TBST for 3 hours at room temperature (RT). After three washes with TBST (10 minutes, RT), a chemiluminescence detection system was used (Thermo Fisher).
Expression of PKA regulatory subunits in HeLa cells
HeLa cells were seeded on 12 mm coverslips placed in 24-well plates at a density of 2.5610 4 cells/well and transfected with Lipofectamine 2000 (Invitrogen) on the following day, according to the manufacturer's instructions. C-terminally GFP-tagged R-subunits are described elsewhere (Prinz et al., 2006a) . Cells were fixed with paraformaldehyde (PFA, 4%, 10 minutes) after 36 hours and stained as described below.
In vitro phosphorylation of PKA regulatory subunits Recombinant human RIIa and RIIb (5 mg) were diluted in 50 ml 20 mM MOPS (pH 7.0), 50 mM NaCl, 10 mM MgCl 2 and 1 mM ATP. Samples were mixed, split in half, spiked with either 100 nM PKA-Ca or buffer, and incubated for 30 minutes at RT. Reactions were stopped by adding 56 SDS sample buffer and heating to 95˚C for 10 minutes.
DRG neuron cultures
L1-L6 DRGs were removed, desheathed, pooled and incubated in Neurobasal A medium supplemented with B27 (Invitrogen) and collagenase P (Roche; 0.2 U/ml) for 1 hour at 37˚C in 5% CO 2 . The neurons were dissociated by trituration with fire-polished Pasteur pipettes. Axon stumps and disrupted cells were removed by BSA gradient centrifugation (15% BSA, 120 g, 8 minutes). Cells were resuspended in Neurobasal A supplemented with B27 medium, plated on 96-well imaging plates (Greiner) or onto glass coverslips precoated with poly-L-ornithin (0.1 mg/ml) and laminin (5 mg/ml), and incubated overnight (37˚C, 5% CO 2 ). Neuron density was ,1500 neurons/cm 2 .
Frozen DRG sections L1-L6 DRGs were fixed with 2% PFA for 4 hours on ice, rinsed three times for 20 minutes with PBS at RT, submerged in 30% sucrose in PBS at 4˚C overnight, embedded in Tissue Tek (EMS Science), and snap frozen on dry ice. Frozen blocks were cut into 10 mm sections, mounted on slides, dried for 30 minutes at RT, and stored at 280˚C. Thawed sections were fixed in 2% PFA for 10 minutes at 4˚C, rinsed in PBS for 30 minutes, and stained as described below.
Stimulation of DRG neurons
DRG neurons were stimulated 24 hours after isolation. Half of the volume (50 ml) was removed from the culture well, mixed with the compound in 96-well V-bottom plates, and added back to the same well. Controls were treated the same way but mixed with solvent only. The cells were fixed by adding 100 ml 8% PFA [final concentration (f.c.) 4%] for 10 minutes at RT. Stimulations were performed in a heated (37˚C) water bath or within the incubator. Neurons were stimulated with the compounds and concentrations as indicated in the text and reagents section.
Immunofluorescence staining
After blocking and permeabilization (2% goat serum, 1% BSA, 0.1% Triton X-100, 0.05% Tween 20 for 1 hour, at RT), sections or cells were incubated with primary antibodies in 1% BSA in PBS at 4˚C overnight. After three washes with PBS (10 minutes, RT), cells were incubated with secondary antibodies (1:1000, 1 hour, RT). After three final washes (30 minutes, RT), the plates were stored at 4˚C until scanning. Sections were mounted with Fluoromount-G (Southern Biotech). Refer to antibodies section for dilutions.
Quantitative microscopy
Stained cultures in 96-well plates were scanned using a Cellomics ArrayScan VTI. Images of 5126512 pixels were acquired with a 106 objective and analyzed using the Cellomics software package. Briefly, images of UCHL1 stainings were background corrected (low pass filtration), converted to binary image masks (fixed threshold), segmented (geometric method), and neurons were identified by the object selection parameters -size: 120-4000 mm The image masks were then used to quantify signals in other channels. For dose-response and time course experiments, raw mean values of triplicate samples were normalized to a mean baseline value from all untreated wells. Bleed-through was compensated as described previously (Roederer, 2002) . Probability density plots were generated using the R package (1D plots) or FlowJo (2D plots). Gating of subpopulations was performed either by setting thresholds at local minima of probability density plots or using threshold free mixture modeling (see below).
fixed with 2% PFA for 20 minutes and immunostained for the respective markers as described above, outside the microscope. All wells were then imaged again with the Arrayscan VTI. Using ImageJ, UCHL1 images were background corrected (rolling ball), converted to binary image masks (Li thresholding), segmented (water shed), and objects were identified by their circularity (4p area/perimeter 2 50.5-1) and size (120-4000 mm 2 ). The single cell masks were then used to determine 340/ 380 nm values as well as RIIb and UCHL1 expression levels for each cell. Then the average calcium traces were calculated for the RIIb(+) and the RIIb(2) neurons. Average traces of three experiments (means 6 s.e.m.) are shown. Living neurons showed a response .25% over the baseline to either capsaicin or KCl.
Mixture modeling of stimulus experiments
The gamma probability distribution, given by the density function:
with shape parameter k, scale parameter h, and ck the gamma function, has been previously suggested as a model for the intracellular distribution of proteins (Friedman et al., 2006) . Population data from control experiments were fitted with a gamma distribution by adjusting the parameters k and h using a maximum-likelihood approach (Choi and Wette, 1969) . For each stimulus experiment a mixture model composed of two gamma distributions was computed. The first mixture component was fixed to the distribution obtained from the control experiment, and the second component was chosen as another gamma distribution with adjustable parameters. The parameters and the component weights were optimized with the expectation maximization algorithm implemented in the software library 'PyMix' (Georgi et al., 2010) . We used a standard hypothesis test based on the likelihood ration to test whether the population model of two gamma distributed subpopulations was statistically significant compared with a model with a single gamma distribution. The null hypothesis was that the population is described by a single gamma distribution, and the alternative hypothesis is that the population is a mixture of two gamma distributions. We used the test statistic T522 log L, where L is the likelihood ratio of the null hypothesis model versus the mixture model (Koch, 2010) . For large sample sizes, the test statistic T is chi-square distributed, and a significance level of P50.001 is achieved for T$10.83. We judged the partitioning as statistically significant, if T$10.83 in each of the three replicates of an experiment.
BRET assay F11 cells were seeded in 96-well plates (Nunc) coated with collagen (Roche) at a density of 1.5610 4 cells/well and cultured in Hams F-12 medium (Sigma-Aldrich) with 15% FCS (PAA) and 1% penicillin and streptomycin (PAA). The cells were transfected after 24 hours using Lipofectamine 2000 (Invitrogen). Cells were rinsed with PBS 48 hours later, treated with the respective reagents for 20 minutes, and the substrate coelenterazine 400a (Biotrend) was added at a final concentration of 5 mM in a total volume of 30 ml PBS prior to the BRET measurement. Light emission was detected with a POLARstar Omega microplate reader (BMG Labtech). For each well the light output was taken simultaneously using filters at the wavelengths 410 nm (680 nm) for the donor and 515 nm (630 nm 
